Acadia Healthcare (NASDAQ:ACHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday.
According to Zacks, “Acadia Healthcare is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 0.8% upward over the last 30 days, which reflects investors' optimism towrads the stock. However, the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are the major headwinds.”
Other research analysts also recently issued research reports about the company. Cantor Fitzgerald lowered their target price on Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a research note on Tuesday, October 24th. Craig Hallum reissued a “buy” rating and set a $41.00 target price (down previously from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Bank of America lowered their target price on Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Deutsche Bank downgraded Acadia Healthcare from a “buy” rating to a “hold” rating and lowered their target price for the stock from $60.00 to $37.00 in a research note on Wednesday, October 25th. Finally, Robert W. Baird downgraded Acadia Healthcare from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $55.00 to $38.00 in a research note on Wednesday, October 25th. Eight equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Acadia Healthcare has an average rating of “Buy” and a consensus target price of $43.92.
In other news, Director Reeve B. Waud sold 100,000 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 11.10% of the company’s stock.
Hedge funds have recently made changes to their positions in the stock. State Street Corp boosted its holdings in Acadia Healthcare by 95.2% in the second quarter. State Street Corp now owns 1,998,030 shares of the company’s stock valued at $98,667,000 after acquiring an additional 974,524 shares during the last quarter. Royal Bank of Canada boosted its holdings in Acadia Healthcare by 25.0% in the second quarter. Royal Bank of Canada now owns 19,306 shares of the company’s stock valued at $954,000 after acquiring an additional 3,856 shares during the last quarter. Nationwide Fund Advisors boosted its holdings in Acadia Healthcare by 5.2% in the third quarter. Nationwide Fund Advisors now owns 259,773 shares of the company’s stock valued at $12,407,000 after acquiring an additional 12,931 shares during the last quarter. Neuberger Berman Group LLC boosted its holdings in Acadia Healthcare by 5.1% in the third quarter. Neuberger Berman Group LLC now owns 879,951 shares of the company’s stock valued at $42,026,000 after acquiring an additional 42,713 shares during the last quarter. Finally, FDx Advisors Inc. bought a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $779,000.
WARNING: This piece of content was reported by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://weekherald.com/2018/02/12/zacks-investment-research-upgrades-acadia-healthcare-achc-to-hold.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.